Viewing Study NCT00245050

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-03-16 @ 8:01 PM
Study NCT ID: NCT00245050
Status: COMPLETED
Last Update Posted: 2011-12-30
First Post: 2005-10-25
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
Sponsor: Case Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Drug/Agent Toxicity by Tissue/Organ View
None Endometrial Cancer View
None Fallopian Tube Cancer View
None Ovarian Cancer View
None Peritoneal Cavity Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None drug/agent toxicity by tissue/organ View
None fallopian tube cancer View
None peritoneal cavity cancer View
None recurrent ovarian epithelial cancer View
None recurrent endometrial carcinoma View
None stage III endometrial carcinoma View
None stage IV endometrial carcinoma View
None stage IV breast cancer View
None male breast cancer View
None recurrent breast cancer View